Hong Kong · Delayed Price · Currency is HKD Fosun International Earnings Call Transcripts
Fiscal Year 2025
-
Revenue declined 9.7% year-on-year to CNY 173.43 billion, with net profit at -CNY 23.4 billion due to non-cash impairments. Overseas revenue rose to 55% of total, and core subsidiaries showed resilient growth, especially in pharma, insurance, and jewelry.
-
Revenue for H1 2025 was ¥87.3 billion, with overseas revenue rising to 53%. Key segments showed mixed results: health and wealth grew in profit, while happiness and manufacturing faced headwinds. Strategic focus remains on innovation, global expansion, and AI adoption.
Fiscal Year 2024
-
Revenue grew 0.8% year-over-year to RMB 97.8 billion, with overseas revenue up 4% and core subsidiaries contributing 74% of total revenue. Leverage and interest-bearing liabilities were reduced, while asset-light and global expansion strategies remain central to future growth.